Cargando…
Differentiation of imatinib -resistant chronic myeloid leukemia cells with BCR-ABL-T315I mutation induced by Jiyuan Oridonin A
Chronic myeloid leukemia (CML) results from BCR-ABL oncogene, which blocks CML cells differentiation and protects these cells from apoptosis. T315I mutated BCR-ABL is the main cause of the resistance mediated by imatinib and second generation BCR-ABL inhibitor. CML with the T315I mutation has been c...
Autores principales: | Xu, Yun, Wang, Ziting, Zhang, Lei, Gao, Congying, Li, Fahui, Li, Xueming, Ke, Yu, Liu, Hong-Min, Hu, Zhenbo, Wei, Liuya, Chen, Zhe-Sheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10197941/ https://www.ncbi.nlm.nih.gov/pubmed/37215441 http://dx.doi.org/10.7150/jca.83219 |
Ejemplares similares
-
Jiyuan oridonin A induces differentiation of acute myeloid leukemia cells including leukemic stem-like cells
por: Li, Fahui, et al.
Publicado: (2022) -
Jiyuan Oridonin A Overcomes Differentiation Blockade in Acute Myeloid Leukemia Cells With MLL Rearrangements via Multiple Signaling Pathways
por: Qu, Mei, et al.
Publicado: (2021) -
I13 overrides resistance mediated by the T315I mutation in chronic myeloid leukemia by direct BCR-ABL inhibition
por: Gao, Congying, et al.
Publicado: (2023) -
Prevalence of BCR-ABL T315I Mutation in Malaysian Patients with Imatinib-Resistant Chronic Myeloid Leukemia
por: Yusoff, Yuslina Mat, et al.
Publicado: (2018) -
A Small Molecule Inhibitor, OGP46, Is Effective against Imatinib-Resistant BCR-ABL Mutations via the BCR-ABL/JAK-STAT Pathway
por: Wei, Liuya, et al.
Publicado: (2020)